✦ LIBER ✦

Early identification of non-remission in first-episode psychosis in a two-year outcome study

✍ Scribed by E. Simonsen; S. Friis; S. Opjordsmoen; E. L. Mortensen; U. Haahr; I. Melle; I. Joa; J. O. Johannessen; T. K. Larsen; J. I. Røssberg; B. R. Rund; P. Vaglum; T. H. McGlashan

Book ID: 109342866
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 113 KB
Volume: 122
Category: Article
ISSN: 0001-690X
DOI: 10.1111/j.1600-0447.2010.01598.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EEG abnormalities and two year outcome i

EEG abnormalities and two year outcome in first episode psychosis

✍ R. Manchanda; R. Norman; A. Malla; R. Harricharan; J. Takhar; S. Northcott 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

A 2-year follow-up of involuntary admiss

A 2-year follow-up of involuntary admission’s influence upon adherence and outcome in first-episode psychosis

✍ S. Opjordsmoen; S. Friis; I. Melle; U. Haahr; J. O. Johannessen; T. K. Larsen; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Course of intelligence deficits in early

Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study

✍ Jens Richardt Moellegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Ann 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 261 KB

Caloric restriction or resveratrol suppl

Caloric restriction or resveratrol supplementation and ageing in a non-human primate: first-year outcome of the RESTRIKAL study inMicrocebus murinus

✍ Alexandre Dal-Pan; Jérémy Terrien; Fabien Pifferi; Roger Botalla; Isabelle Hardy 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 615 KB

A two-year prospective follow-up study o

A two-year prospective follow-up study of the outcome after surgery in patients with slipped lumbar disk operated upon for the first time

✍ L. V. Sørensen; O. Mors 📂 Article 📅 1989 🏛 Springer Vienna 🌐 English ⚖ 680 KB

Early clinical remission and normalisati

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

✍ L. S. Kiss; T. Szamosi; T. Molnar; P. Miheller; L. Lakatos; A. Vincze; K. Palatk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB